BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 26320195)

  • 1. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients.
    Sivaraman S; Kraguljac NV; White DM; Morgan CJ; Gonzales SS; Lahti AC
    Psychiatry Res Neuroimaging; 2018 Nov; 281():101-106. PubMed ID: 30286325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
    Brandt AS; Unschuld PG; Pradhan S; Lim IA; Churchill G; Harris AD; Hua J; Barker PB; Ross CA; van Zijl PC; Edden RA; Margolis RL
    Schizophr Res; 2016 Apr; 172(1-3):101-5. PubMed ID: 26925800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.
    Öngür D; Jensen JE; Prescot AP; Stork C; Lundy M; Cohen BM; Renshaw PF
    Biol Psychiatry; 2008 Oct; 64(8):718-726. PubMed ID: 18602089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.
    Strzelecki D; Podgórski M; Kałużyńska O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Int J Mol Sci; 2015 Oct; 16(10):24475-89. PubMed ID: 26501260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
    Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
    Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
    Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.
    Kierans AS; Kirov II; Gonen O; Haemer G; Nisenbaum E; Babb JS; Grossman RI; Lui YW
    Neurology; 2014 Feb; 82(6):521-8. PubMed ID: 24401686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
    Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
    Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
    Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
    Wood SJ; Berger GE; Wellard RM; Proffitt T; McConchie M; Velakoulis D; McGorry PD; Pantelis C
    Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
    de la Fuente-Sandoval C; León-Ortiz P; Azcárraga M; Stephano S; Favila R; Díaz-Galvis L; Alvarado-Alanis P; Ramírez-Bermúdez J; Graff-Guerrero A
    JAMA Psychiatry; 2013 Oct; 70(10):1057-66. PubMed ID: 23966023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
    Shutter L; Tong KA; Holshouser BA
    J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation.
    Chiappelli J; Hong LE; Wijtenburg SA; Du X; Gaston F; Kochunov P; Rowland LM
    Transl Psychiatry; 2015 Apr; 5(4):e548. PubMed ID: 25871973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.